Intrinsic Value of S&P & Nasdaq Contact Us

Nautilus Biotechnology, Inc. NAUT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
33/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.50
-18.3%

Nautilus Biotechnology, Inc. (NAUT) has 12 identified peers for comparison in the Healthcare sector. Peers include ANEB, BCAB, BEAM, CCCC, CRBU, CSBR and others.

NAUT has a market capitalization of $387.29M, compared to an average peer market cap of $371.43M.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message